Analytical Tool - Angiogenesis In Oncology

NEW YORK, Feb. 6, 2012 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue: Analytical Tool - Angiogenesis in Oncology

http://www.reportlinker.com/p0284896/Analytical-Tool---Angiogenesis-in-Oncology.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=General_Medicine_and_Specialty_Medicine

"Analytical Tool - Angiogenesis in Oncology" offers a unique tool for analyzing the vast amount of strategic possibilities that have emerged in anti-angiogenic drug development for the treatment of cancer. It is at the same time a map of the research and development, a history of the achievements up to date, and a guide pointing out the directions of the future. The product as well, lays the framework of current treatment strategies and their progress. This tool provides you with an immense amount of information structured and analyzed to assist you in your work. It is designed to assist you in finding right partners, optimizing your licensing deals, wisely choosing which projects give you the best competitive advantage, and assuring you that your decisions have been based on the most accurate, validated and precise facts available. Included in this advantageous package are two products already appreciated by many of our customers:

Commercializing Angiogenesis Affecting Drugs in Cancer: The Faster Route to Consider Your Options and Position of Others

Angiogenesis in Oncology: Drug Pipeline Update 2011* The Package Includes

* A progress analysis on current and emerging drugs * Information on most companies active in anti-angiogenic R&D in oncology* Information on key industry related anti-angiogenic drug projects in oncology* Data from most important clinical trials * Information on early developmental stage projects * Possibility of performing advanced searches suited to your individual needs

This Tool will Assist You in:

* Tracking cutting edge companies, therapies and new technologies

* Rapid identification of partners & competitors